Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.
van Rensburg SJ, van Toorn R, Erasmus RT, Hattingh C, Johannes C, Moremi KE, Kemp MC, Engel-Hills P, Kotze MJ. van Rensburg SJ, et al. Among authors: hattingh c. Metab Brain Dis. 2021 Aug;36(6):1151-1167. doi: 10.1007/s11011-021-00711-w. Epub 2021 Apr 28. Metab Brain Dis. 2021. PMID: 33909200 Review.
Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases.
van Rensburg SJ, Hattingh C, Johannes C, Moremi KE, Peeters AV, van Heerden CJ, Erasmus RT, Zemlin AE, Kemp MC, Jaftha M, Khine AA, Potocnik FCV, Whati L, Engel-Hills P, van Toorn R, Kotze MJ. van Rensburg SJ, et al. Among authors: hattingh c. Metab Brain Dis. 2021 Aug;36(6):1169-1181. doi: 10.1007/s11011-021-00712-9. Epub 2021 Mar 12. Metab Brain Dis. 2021. PMID: 33710528 Review.
Correction to: Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases.
van Rensburg SJ, Hattingh C, Johannes C, Moremi KE, Peeters AV, van Heerden CJ, Erasmus RT, Zemlin AE, Kemp MC, Jaftha M, Khine AA, Potocnik FCV, Whati L, Engel-Hills P, van Toorn R, Kotze MJ. van Rensburg SJ, et al. Among authors: hattingh c. Metab Brain Dis. 2021 Aug;36(6):1183-1184. doi: 10.1007/s11011-021-00722-7. Metab Brain Dis. 2021. PMID: 33909201 No abstract available.
Grey matter abnormalities in social anxiety disorder: a pilot study.
Syal S, Hattingh CJ, Fouché JP, Spottiswoode B, Carey PD, Lochner C, Stein DJ. Syal S, et al. Among authors: hattingh cj. Metab Brain Dis. 2012 Sep;27(3):299-309. doi: 10.1007/s11011-012-9299-5. Epub 2012 Apr 22. Metab Brain Dis. 2012. PMID: 22527992 Clinical Trial.
(1)H-magnetic resonance spectroscopy in social anxiety disorder.
Howells FM, Hattingh CJ, Syal S, Breet E, Stein DJ, Lochner C. Howells FM, et al. Among authors: hattingh cj. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr 3;58:97-104. doi: 10.1016/j.pnpbp.2014.12.008. Epub 2014 Dec 27. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 25549832
Voxel-based morphometry multi-center mega-analysis of brain structure in social anxiety disorder.
Bas-Hoogendam JM, van Steenbergen H, Nienke Pannekoek J, Fouche JP, Lochner C, Hattingh CJ, Cremers HR, Furmark T, Månsson KNT, Frick A, Engman J, Boraxbekk CJ, Carlbring P, Andersson G, Fredrikson M, Straube T, Peterburs J, Klumpp H, Phan KL, Roelofs K, Veltman DJ, van Tol MJ, Stein DJ, van der Wee NJA. Bas-Hoogendam JM, et al. Among authors: hattingh cj. Neuroimage Clin. 2017 Aug 30;16:678-688. doi: 10.1016/j.nicl.2017.08.001. eCollection 2017. Neuroimage Clin. 2017. PMID: 30140607 Free PMC article.
Pharmacotherapy for social anxiety disorder (SAnD).
Williams T, Hattingh CJ, Kariuki CM, Tromp SA, van Balkom AJ, Ipser JC, Stein DJ. Williams T, et al. Among authors: hattingh cj. Cochrane Database Syst Rev. 2017 Oct 19;10(10):CD001206. doi: 10.1002/14651858.CD001206.pub3. Cochrane Database Syst Rev. 2017. PMID: 29048739 Free PMC article. Review.
19 results